An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease.
Yap
L M
LM
Hagan
S
S
Craig
A
A
Hebbard
G G
GG
Young
G P
GP
Bampton
P A
PA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D015331:Cohort Studies; D004837:Epinephrine / Q000008:administration & dosage*; D005773:Gastroscopy / Q000379:methods; D016558:Hemostasis, Endoscopic / Q000379:methods*; D006801:Humans; D007262:Infusions, Intravenous; D015552:Injections, Intralesional; D017075:Laser Coagulation / Q000379:methods*; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D010438:Peptic Ulcer Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011446:Prospective Studies; D017494:Proton Pumps; D012189:Retrospective Studies; D013454:Sulfoxides / Q000008:administration & dosage*; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D017494:Proton Pumps; D013454:Sulfoxides; D014662:Vasoconstrictor Agents; D000077402:Pantoprazole; D009853:Omeprazole; D004837:Epinephrine